Board moves provisional mpox and carbapenemase organism reporting into permanent rulemaking

The Washington State Board of Health voted to authorize rulemaking that would make two provisional reporting requirements permanent: mpox (monkeypox) and carbapenemase‑producing organisms (CPOs), while noting that COVID‑19 rule changes are already in flight and that the timing of any COVID‑19 rule amendments will influence sequencing of work.

State epidemiologist Scott Lindquist explained the provisional reporting safety valve that allows the state health officer to require time‑limited reporting before permanent rulemaking: laboratory reporting of mpox and expanded species reporting for carbapenemase‑producing organisms has already helped detect outbreaks and inform public‑health intervention.

Lindquist showed the state’s multidrug‑resistant organism dashboard and said the identification of CPOs enabled public‑health action to stop transmission in health‑care settings. “This is a huge issue for Washington state,” he said, describing increasing detection of these organisms and the value of rapid laboratory reporting.

Board members voted to start the formal rulemaking process for mpox and CPOs, directing staff to file CR101/CR102 materials after concluding the ongoing COVID‑19 rulemaking work so that rule sections are not duplicatively amended. The board emphasized that permanent reporting will improve outbreak detection and reduce silent spread of resistant organisms.